362. Deputy Seán Ó Fearghaíl asked the Minister for Health whether the oncology nurse coordinator post at Naas General Hospital has been discontinued, reassigned or reconfigured; the reasons for any such decision; whether a clinical or service impact assessment was carried out in advance; the arrangements currently in place for the coordination of care for oncology patients attending the hospital; and whether staffin…
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
340 questions match, newest first.
363. Deputy Seán Ó Fearghaíl asked the Minister for Health if she is aware of concerns raised by patients and families affected by phenylketonuria (PKU) regarding access to a medicinal product (details supplied); if the product has been assessed, or is under assessment, for reimbursement and availability in Ireland; the current status of any application for pricing and reimbursement of this treatment; and the timelin…
364. Deputy Marie Sherlock asked the Minister for Health the name of each cancer specific drug currently being administered with the support of private insurance in acute hospitals. [66175/26]
366. Deputy Marie Sherlock asked the Minister for Health the name of each cancer specific drug that was approved by HSE’s EMT for approval for each of the years 2019 to date in 2026. [66173/26]
367. Deputy Marie Sherlock asked the Minister for Health the cost of extending bowel screening to those aged between 50 and 57. [66172/26]
368. Deputy Pádraig Rice asked the Minister for Health further to Parliamentary Question No. 3148 of 28 July 2026, if she intends to progress any long-term supports for healthcare workers with long Covid; and to provide an update on her Department's engagements with the Department of Public Expenditure, Infrastructure, Public Service Reform and Digitalisation with respect to this matter. [66171/26]
369. Deputy Pádraig Rice asked the Minister for Health if consideration is being given to the inclusion of an emergency treatment for severe allergic reactions under the drugs payment scheme (details supplied). [66170/26]
370. Deputy Marie Sherlock asked the Minister for Health the name of each cancer specific drug that was submitted to the HSE’s EMT for approval for each of the years 2019 to date in 2026. [66169/26]
371. Deputy Pádraig Rice asked the Minister for Health the annual cost to the Exchequer of each of the three helicopter emergency medical services operated by, or on behalf of, the National Ambulance Service (details supplied), identifying separately in each case the annual contract or operating cost; the operator, the contract duration and expiry date where the service is contracted; and the daily hours of operation…
372. Deputy Marie Sherlock asked the Minister for Health the number of new cancer specific drugs approved for reimbursement by the HSE for each of the years 2019 to date in 2026. [66166/26]
373. Deputy Pádraig Rice asked the Minister for Health to provide a breakdown of home support provision by type, region and integrated healthcare area (details supplied). [66223/26]
374. Deputy Pádraig Rice asked the Minister for Health the status of the new Healthy Ireland Framework following the conclusion of the Healthy Ireland Framework 2013–2025; the reasons for the delay in its launch; the revised timeline for its publication; and if she will make a statement on the matter. [66190/26]
375. Deputy Marie Sherlock asked the Minister for Health the names of cancer specific drugs being administered via a clinical trial in 2026. [66189/26]
376. Deputy Marie Sherlock asked the Minister for Health the consideration, if any, her Department has given to targeted, risk stratified cancer screening for lung cancer for persons. [66188/26]
377. Deputy Marie Sherlock asked the Minister for Health the number of cancer specific drugs being administered via a clinical trial for each of the years from 2019 to date in 2026. [66187/26]
379. Deputy Marie Sherlock asked the Minister for Health the consideration her Department has given to targeted, risk stratified cancer screening for breast cancer for persons under the age 50. [66185/26]
380. Deputy Marie Sherlock asked the Minister for Health the name of each non cancer specific drug that is being administered with the support of private insurance in acute hospitals in 2026. [66184/26]
382. Deputy Marie Sherlock asked the Minister for Health the number of non cancer specific drugs being administered with the support of private insurance in acute hospitals for each of the years 2019 to date in 2026. [66181/26]
383. Deputy Marie Sherlock asked the Minister for Health the consideration, if any, her Department has given to targeted, risk stratified cancer screening for bowel cancer for persons under the age of 57. [66180/26]
385. Deputy Marie Sherlock asked the Minister for Health the cost, if any, of imparting breast density information in each mammogram or breast scan. [66178/26]
386. Deputy Marie Sherlock asked the Minister for Health the number of cancer specific drugs being administered with the support of private insurance in acute hospitals for each of the years 2019 to date in 2026. [66177/26]
387. Deputy Marie Sherlock asked the Minister for Health the cost of extending bowel screening to those aged between 45 and 57. [66176/26]
388. Deputy Colm Burke asked the Minister for Health whether she has plans to introduce a population-wide cardiovascular health check programme in Ireland, in line with the ambitions of the EU Safe Hearts Plan. [66231/26]
390. Deputy Pádraig Rice asked the Minister for Health the number of occasions that a request for helicopter emergency medical service was not met because the request was made outside the hours of operation of the service in each of the years 2024 and 2025. [66165/26]
392. Deputy Colm Burke asked the Minister for Health whether the forthcoming National Cardiovascular Health Strategy will be developed as a comprehensive National Cardiovascular Health Strategy that builds upon the recommendations of the National Review of Adult Specialist Cardiac Services while also aligning with the objectives of the European Commission's Safe Hearts Plan and the forthcoming EU Council Recommendati…